P200: 7α-Hydroxy-4-cholesten-3-one for diagnosis and management of bile acid malabsorption in IBD patients: 2-year clinical experience
ECCO '19 Copenhagen
2019
P201: Faecal calprotectin in healthy children: are there factors affecting levels other than age?
ECCO '19 Copenhagen
2019
P202: Quantum blue anti-infliximab: development and evaluation of a point of care rapid test for measuring anti-infliximab antibodies in human serum
ECCO '19 Copenhagen
2019
P204: The predictive value of ileocaecal resection margins for postoperative Crohn’s recurrence
ECCO '19 Copenhagen
2019
P205: The impact of the severity of microscopic inflammation at the time of diagnosis on UC-related outcomes during follow-up
ECCO '19 Copenhagen
2019
P206: Colectomy rate in paediatric patients with ulcerative colitis is decreasing
ECCO '19 Copenhagen
2019
P207: 67-Gallium citrate oral Scintigraphy evaluation in inflammatory activity in Crohn′s disease: a new highlighter?
ECCO '19 Copenhagen
2019
P208: Impact of Pillcam Crohn's capsule on diagnostic yield and clinical management: results of the first multi-centre, observational study
ECCO '19 Copenhagen
2019
P209: Rates of wound healing in patients with Crohn’s disease undergoing proctectomy
ECCO '19 Copenhagen
2019
P210: Depression and anxiety disorders impact in the quality of life of patients with inflammatory bowel disease
ECCO '19 Copenhagen
2019
P211: Relationship between the concentrations of free sulphates and 5-hydroxyindoleacetic acid (5-HIAA) in urine for IBD patients
ECCO '19 Copenhagen
2019
P212: Diagnostic approach to monogenic inflammatory bowel disease in clinical practice: a 10-year multi-centric experience
ECCO '19 Copenhagen
2019
P213: Raised faecal calprotectin in inflammatory bowel disease (IBD) patients: 100% accurate or potential red herring?
ECCO '19 Copenhagen
2019
P214: How to incorporate patients preference into ulcerative colitis current clinical management: initial document from a Spanish multidisciplinary steering committee
ECCO '19 Copenhagen
2019
P215: The mean platelet volume compared with other serum biomarkers: is it predictive of activity of Crohn’s disease?
ECCO '19 Copenhagen
2019
P216: Impact of disease knowledge on quality of life of inflammatory bowel disease patients
ECCO '19 Copenhagen
2019
P217: Serological biomarkers of type VI collagen remodelling reflect endoscopically and clinically active Crohn’s disease
ECCO '19 Copenhagen
2019
P218: The cost-effectiveness of biological therapy cycles in the management of Crohn’s disease
ECCO '19 Copenhagen
2019